10
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Benefits and harms of breast cancer mammography screening for women at average risk of breast cancer: A systematic review for the European Commission Initiative on Breast Cancer

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Objectives

          Mammography screening is generally accepted in women aged 50–69, but the balance between benefits and harms remains controversial in other age groups. This study systematically reviews these effects to inform the European Breast Cancer Guidelines.

          Methods

          We searched PubMed, EMBASE and Cochrane Library for randomised clinical trials (RCTs) or systematic reviews of observational studies in the absence of RCTs comparing invitation to mammography screening to no invitation in women at average breast cancer (BC) risk. We extracted data for mortality, BC stage, mastectomy rate, chemotherapy provision, overdiagnosis and false-positive-related adverse effects. We performed a pooled analysis of relative risks, applying an inverse-variance random-effects model for three age groups (<50, 50–69 and 70–74). GRADE (Grading of Recommendations Assessment, Development and Evaluation) was used to assess the certainty of evidence.

          Results

          We identified 10 RCTs including 616,641 women aged 38–75. Mammography reduced BC mortality in women aged 50–69 (relative risk (RR) 0.77, 95%CI (confidence interval) 0.66–0.90, high certainty) and 70–74 (RR 0.77, 95%CI 0.54–1.09, high certainty), with smaller reductions in under 50s (RR 0.88, 95%CI 0.76–1.02, moderate certainty). Mammography reduced stage IIA+ in women 50–69 (RR 0.80, 95%CI 0.64–1.00, very low certainty) but resulted in an overdiagnosis probability of 23% (95%CI 18–27%) and 17% (95%CI 15–20%) in under 50s and 50–69, respectively ( moderate certainty). Mammography was associated with 2.9% increased risk of invasive procedures with benign outcomes ( low certainty).

          Conclusions

          For women 50–69, high certainty evidence that mammography screening reduces BC mortality risk would support policymakers formulating strong recommendations. In other age groups, where the net balance of effects is less clear, conditional recommendations will be more likely, together with shared decision-making.

          Related collections

          Most cited references1

          • Record: found
          • Abstract: not found
          • Book: not found

          Global cancer observatory cancer today

            Bookmark

            Author and article information

            Contributors
            (View ORCID Profile)
            (View ORCID Profile)
            (View ORCID Profile)
            (View ORCID Profile)
            Journal
            Journal of Medical Screening
            J Med Screen
            SAGE Publications
            0969-1413
            1475-5793
            February 25 2021
            : 096914132199386
            Affiliations
            [1 ]CIBER de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain
            [2 ]Department of Clinical Epidemiology and Public Health, Iberoamerican Cochrane Centre, Biomedical Research Institute Sant Pau (IIB Sant Pau), Barcelona, Spain
            [3 ]Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia
            [4 ]Department of Epidemiology and Evaluation, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain
            [5 ]European Commission, Joint Research Centre (JRC), Ispra, VA, Italy
            [6 ]Epidemiology Unit, AUSL – IRCCS di Reggio Emilia, RE, Italy
            [7 ]Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK
            [8 ]German Cancer Society, Berlin, Germany
            [9 ]Radiologie am Theater, Paderborn, Germany
            Article
            10.1177/0969141321993866
            33632023
            3e3a5a04-c29d-4d63-87d6-829341c0433a
            © 2021

            https://creativecommons.org/licenses/by-nc/4.0/

            History

            Comments

            Comment on this article